Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis.

Arentz S, Smith CA, Abbott J, Bensoussan A.

BMC Complement Altern Med. 2017 Nov 25;17(1):500. doi: 10.1186/s12906-017-2011-x. Review.


Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD+-dependent scyllo-inositol dehydrogenase.

Kang DM, Michon C, Morinaga T, Tanaka K, Takenaka S, Ishikawa S, Yoshida KI.

BMC Microbiol. 2017 Jul 11;17(1):154. doi: 10.1186/s12866-017-1065-8.


Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.

Sortino MA, Salomone S, Carruba MO, Drago F.

Front Pharmacol. 2017 Jun 8;8:341. doi: 10.3389/fphar.2017.00341. eCollection 2017. Review.


Inositol and In Vitro Fertilization with Embryo Transfer.

Simi G, Genazzani AR, Obino ME, Papini F, Pinelli S, Cela V, Artini PG.

Int J Endocrinol. 2017;2017:5469409. doi: 10.1155/2017/5469409. Epub 2017 Feb 28. Review.


Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials.

Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F.

Int J Endocrinol. 2016;2016:1849162. Epub 2016 Oct 23. Review.


Inositol Treatment and ART Outcomes in Women with PCOS.

Garg D, Tal R.

Int J Endocrinol. 2016;2016:1979654. Epub 2016 Oct 4. Review.


The inositols and polycystic ovary syndrome.

Kalra B, Kalra S, Sharma JB.

Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):720-724.


Inositols in the Treatment of Insulin-Mediated Diseases.

Muscogiuri G, Palomba S, Laganà AS, Orio F.

Int J Endocrinol. 2016;2016:3058393. doi: 10.1155/2016/3058393. Epub 2016 Sep 8. Review. Erratum in: Int J Endocrinol. 2016;2016:6189820.


Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol.

Sacchi S, Marinaro F, Tondelli D, Lui J, Xella S, Marsella T, Tagliasacchi D, Argento C, Tirelli A, Giulini S, La Marca A.

Reprod Biol Endocrinol. 2016 Aug 31;14(1):52. doi: 10.1186/s12958-016-0189-2.


The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Thomas MP, Mills SJ, Potter BV.

Angew Chem Int Ed Engl. 2016 Jan 26;55(5):1614-50. doi: 10.1002/anie.201502227. Epub 2015 Dec 22. Review.


(1)H HR-MAS NMR Spectroscopy and the Metabolite Determination of Typical Foods in Mediterranean Diet.

Corsaro C, Mallamace D, Vasi S, Ferrantelli V, Dugo G, Cicero N.

J Anal Methods Chem. 2015;2015:175696. doi: 10.1155/2015/175696. Epub 2015 Oct 1.


Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.

Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, Manna C, Vaquero E, Caserta D, Raparelli V, Marci R, Moscarini M.

Reprod Biol Endocrinol. 2012 Jul 23;10:52. doi: 10.1186/1477-7827-10-52.


Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.

Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE.

Metab Syndr Relat Disord. 2010 Apr;8(2):127-36. doi: 10.1089/met.2009.0052.


d- chiro-Inositol is absorbed but not synthesised in rodents.

Lin X, Ma L, Gopalan C, Ostlund RE.

Br J Nutr. 2009 Nov;102(10):1426-34. doi: 10.1017/S0007114509990456. Epub 2009 Jul 9.


Rat L6 myotubes as an in vitro model system to study GLUT4-dependent glucose uptake stimulated by inositol derivatives.

Yap A, Nishiumi S, Yoshida K, Ashida H.

Cytotechnology. 2007 Dec;55(2-3):103-8. doi: 10.1007/s10616-007-9107-y. Epub 2007 Oct 31.


Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.

Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E.

Hum Reprod. 2008 Jun;23(6):1439-46. doi: 10.1093/humrep/den097. Epub 2008 Mar 29.

Supplemental Content

Support Center